§ Federal grant opportunity · PAR-25-415
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed). The deadline is September 7, 2028 and the published award range is $125K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- September 7, 2028
- Award range
- $125K
- Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Geography
- United States
- Focus areas
- Education, Environment, Food Security, Health, Human Services
- Opportunity number
- PAR-25-415
Program overview
The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE-First awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who have not had any prior independent, peer-reviewed, external research grants, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 7, 2028, allowing time for registration and validation.
Related grant opportunities
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
- Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
- NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.